Potential of a Hec1 Inhibitor as Treatment for Primary Liver Cancer
Algolia Search
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

Potential of a Hec1 Inhibitor as Treatment for Primary Liver Cancer

Highly expressed in cancer protein 1 (Hec1) is an oncogene and a promising molecular target for novel anticancer drugs. The purpose of this study was to evaluate the potential of a Hec1 inhibitor, TAI-95, as a treatment for primary liver cancer.

https://jumpshare.com/v/bossbnQDr3XVNtXlDlxD